Pine Valley Investments’s Bristol-Myers Squibb BMY Stock Holding History

Pine Valley Investments’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.48M	Buy	43,011 +1,088	+3%	+$62.5K	0.1%	191
2026 Q1	$2.54M	Sell	41,923 -15	-0%	-$874	0.12%	175
2025 Q4	$2.26M	Sell	41,938 -1,110	-3%	-$53.4K	0.11%	182
2025 Q3	$1.94M	Sell	43,048 -604	-1%	-$28.2K	0.1%	201
2025 Q2	$2.02M	Buy	43,652 +1,241	+3%	+$60.9K	0.11%	185
2025 Q1	$2.59M	Sell	42,411 -2,352	-5%	-$137K	0.16%	153
2024 Q4	$2.53M	Sell	44,763 -134	-0.3%	-$7.49K	0.15%	149
2024 Q3	$2.32M	Buy	44,897 +575	+1%	+$27K	0.14%	157
2024 Q2	$1.84M	Buy	44,322 +827	+2%	+$37K	0.12%	168
2024 Q1	$2.36M	Sell	43,495 -2,301	-5%	-$117K	0.16%	141
2023 Q4	$2.35M	Sell	45,796 -1,882	-4%	-$98.8K	0.17%	134
2023 Q3	$2.77M	Buy	47,678 +4,888	+11%	+$300K	0.25%	91
2023 Q2	$2.74M	Buy	42,790 +36,150	+544%	+$2.42M	0.27%	84
2023 Q1	$406K	Buy	+6,640	New	+$468K	0.06%	194

Other funds holding BMY

Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

KBC Group Brussels, Belgium $46.3B AUM 43.9% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

SAM

SEB Asset Management Stockholm $26.6B AUM

Pine Valley Investments's BMY Position: Q2 2026 in Review

Pine Valley Investments increased its Bristol-Myers Squibb (BMY) stake by 2.6% in Q2 2026, buying an estimated $62.5K and bringing the position to 43,011 shares worth $2.48M. The position accounts for 0.1% of the portfolio, ranked #191.

Pine Valley Investments first reported a position in BMY in Q1 2023 and has held it in 14 quarters since. The position peaked at $2.77M in Q3 2023. 1,393 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

Pine Valley Investments held 43,011 shares of Bristol-Myers Squibb worth $2.48M as of Q2 2026.
Pine Valley Investments bought 1,088 Bristol-Myers Squibb shares in Q2 2026, an estimated $62.5K.
Bristol-Myers Squibb made up 0.1% of Pine Valley Investments's portfolio in Q2 2026, its #191 holding.
Pine Valley Investments first reported a position in Bristol-Myers Squibb in Q1 2023 and has held it in 14 quarters since.
Pine Valley Investments's Bristol-Myers Squibb position peaked at $2.77M in Q3 2023.
1,393 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Pine Valley Investments's 13F filing for Q2 2026, filed 24 Jul 2026.